COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 845: Articles 8441-8450  | Next

Early SARS-CoV-2 reinfections within 60 days highlight the need to consider antigenic variations together with duration of immunity in defining retesting policies
Nevejan, L., Cuypers, L., Laenen, L., Van Loo, L., Vermeulen, F., Wollants, E., Van Hecke, I., Desmet, S., Lagrou, K., Maes, P., Andre, E.
10.1101/2022.04.04.22273172 — Posted: 2022-04-07
Combined Infection Control Interventions Protect the Essential Workforce from Occupationally-Acquired SARS-CoV-2 during Produce Production, Harvesting and Processing Activities
Cooper, D. K., Sobolik, J. S., Kovacevic, J., Rock, C., Sajewski, E. T., Guest, J. L., Lopman, B. A., Jaykus, L.-A., Leon, J. S.
10.1101/2022.04.06.22273125 — Posted: 2022-04-07
Vaccine effectiveness of BNT162b2 against Omicron and Delta outcomes in adolescents
Buchan, S. A., Nguyen, L., Wilson, S. E., Kitchen, S. A., Kwong, J.
10.1101/2022.04.07.22273319 — Posted: 2022-04-07
Impact of the COVID-19 epidemic on mortality in rural coastal Kenya
Otiende, M., Nyaguara, A., Bottomley, C., Walumbe, D., Mochamah, G., Amadi, D., Nyundo, C., Kagucia, E., Etyang', A., Adetifa, I., Maitha, E., Chondo, E., Nzomo, E., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., Ng'ang'a, W., Barasa, E., Tsofa, B., Mwangangi, J., Bejon, P., Agweyu, A., Williams, T., Scott, A.
10.1101/2022.04.06.22273516 — Posted: 2022-04-07
Prediction of deterioration from COVID-19 in patients in skilled nursing facilities using wearable and contact-free devices: a feasibility study
Von Preyss-Friedman, S., Emmet, L., Deckert, D., David, D. A. B., Raisanen, H., Longoria, K., Gielen, W., Frasch, M. G.
10.1101/2022.04.06.22273202 — Posted: 2022-04-07
Use of face masks did not impact COVID-19 incidence among 10-12-year-olds in Finland
Juutinen, A., Sarvikivi, E., Laukkanen-Nevala, P., Helve, O.
10.1101/2022.04.04.22272833 — Posted: 2022-04-07
STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study Protocol.
van der Feltz-Cornelis, C. M., Sweetman, J., Allsopp, G., Attree, E., Crooks, M. G., Cuthbertson, D. J., Forshaw, D., Gabbay, M., Green, A., Heightman, M., Hillman, T., Hishmeh, L., Khunti, K., Lip, G. Y. H., Lorgelly, P., Montgomery, H., Strain, W. D., Wall, E., Watkins, C., Williams, N., Wootton, D. G., Banerjee, A.
10.1101/2022.04.06.22273514 — Posted: 2022-04-07
Distinct evolutionary trajectories of SARS-CoV-2 interacting proteins in bats and primates identify important host determinants of COVID-19
Cariou, M., Picard, L., Gueguen, L., Jacquet, S., Cimarelli, A., Fregoso, O. I., Molaro, A., Navratil, V., Etienne, L.
10.1101/2022.04.07.487460 — Posted: 2022-04-07
Antibody Resistance of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2 and BA.3 Sub-lineages
Ai, J., Wang, X., He, X., Zhao, X., Zhang, Y., Jiang, Y., Li, M., Cui, Y., Chen, Y., Qiao, R., Li, L., Yang, L., Li, Y., Hu, Z., Zhang, W., Wang, P.
10.1101/2022.04.07.487489 — Posted: 2022-04-07
Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits mucosal immunity and prevents SARS CoV-2 infection and pathology
Shamseldin, M. M., Zani, A., Kenney, A., Evans, J., Zeng, C., Read, K. A., Caution, K., Hall, J. M., Brown, J. M., Gunsch, G., Corps, K. N., Chaitwatponsakom, S., KC, M., Lu, M., Deora, R., Peeples, M. E., Li, J., Oestreich, K. J., Liu, S.-L., Yount, J. S., Dubey, P.
10.1101/2022.04.06.487394 — Posted: 2022-04-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).